Artemis Q4 Revenue up 7%, EBITDA Rises 21%, Net Profit Jumps 60%

14 May 2025 CW Team

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.

For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.

Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.

To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

The Board of Directors of Artemis Medicare Services today approved the company’s audited financial results for the 4th quarter (Jan to Mar) and 12M (Apr to Mar) for the financial year 2024 – 25.For the quarter ended March 31, 2025 Artemis Medicare Services, on a consolidated level, registered a gross revenue of Rs 2,521 Million, an increase of 7.0 per cent over the same period last fiscal. For the fiscal year (April – March), the company’s gross revenue closed at Rs 9,819 Million, an increase of 6.5 per cent over the same period last fiscal. The Board of Directors have recommended a final dividend of 45 per cent per Equity Share of face value of Re 1 each for FY25, subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM) of the Company.Commenting on the company’s performance, Onkar Kanwar, Chairman, Artemis Medicare Services said “Artemis concluded FY25 on a strong and positive trajectory, delivering consistent performance and steady growth across the year. We have continued to advance in both clinical excellence and operational capabilities, reaffirming our commitment to provide high-quality, accessible healthcare to the communities we serve. During the year we also inaugurated our third tower, which will be commissioned in a phase-wise manner to accommodate the increasing demand from our growing patient base.To fuel our next growth phase, we raised Rs 3.30 billion from the International Finance Corporation (IFC), enabling strategic expansion across Delhi NCR and select Tier 2 cities through both brownfield and greenfield projects. The Board has approved a long-term Operations & Management and Medical Services Agreement for a 300+ bed super-speciality hospital in Raipur. This deal marks a key step in expanding our footprint in Central India and reinforces our mission to deliver advanced healthcare solutions across geographies. As we look ahead, our unwavering focus remains on creating long-term value for our patients, shareholders, and employees, while building Artemis into one of India’s most trusted and respected healthcare brands.”

Equipment

12 Dec 2025

Escorts Kubota Unveils BS V Next-gen Construction Range at Excon 2025

Escorts Kubota (EKL), one of India’s major engineering groups in the agricultural and construction equipment sectors, unveiled its latest BS V–compliant construction machinery line-up at Excon 2025. The refreshed portfolio underscores the company’s push toward application-driven, high-productivity solutions that reduce ownership costs and meet the needs of India’s expanding infrastructure landscape. With demand rising across urban development, industrial logistics and mining, the new range aims to deliver higher performance, durability and operator comfort.In the earthmoving segment, E..

Equipment

12 Dec 2025

ACE and Kotak Mahindra Bank Join Hands to Boost Backhoe Loader Financing

Action Construction Equipment (ACE), the world’s largest Pick-n-Carry crane maker and a leading manufacturer of material handling and construction equipment in India, has entered into a Memorandum of Understanding with Kotak Mahindra Bank to enhance the availability of flexible financing options for backhoe loader customers across the country.The collaboration aims to support contractors, infrastructure companies, entrepreneurs, SMEs, and emerging businesses by offering smoother access to credit through customised loan schemes, quicker turnaround times, and the extensive footprint of Kotak M..

Building Material

11 Dec 2025

Suraj Estate Wins Euromoney Award for India’s Best Residential Developer

"Suraj Estate Developers Limited has received the Euromoney Real Estate Award 2025 for ‘India’s Best Residential Developer’, positioning the company among globally benchmarked leaders in the sector. The recognition reflects its four-decade legacy in delivering high-quality residential and redevelopment-led projects across South Central Mumbai. The Euromoney Real Estate Awards, presented by the London-based Euromoney magazine, are widely regarded as one of the most credible global assessments of performance in real estate, banking and finance. Winners are selected through surveys of inte..